GP Capital is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Shanghai. The company was established in Asia in China.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the GP Capital, startups are often financed by ZhenFund, Samsung Ventures, Wardenclyffe Partners. The meaningful sponsors for the fund in investment in the same round are Tianxing Capital, Samsung Ventures, Qiming Venture Partners. In the next rounds fund is usually obtained by Zhangjiang Torch Venture Capital Co, ZSVC, ZJ Innopark (Zhangjiang Hi-Tech Park).
The high activity for fund was in 2019. The typical startup value when the investment from GP Capital is more than 1 billion dollars. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 33 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
The overall number of key employees were 1.
Among the most popular fund investment industries, there are Therapeutics, Robotics. Among the most popular portfolio startups of the fund, we may highlight Suning Finance, Huimin, Quanergy Systems. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.
|9Mile Labs||Seattle, United States, Washington|
|Archimedes Labs||California, Palo Alto, United States|
|Diverse Middle East FZE||-|
|Ellis International||Minneapolis, Minnesota, United States|
|Eminent Venture Capital||-|
|Fuxi Touzi||China, Ningbo, Zhejiang|
|Global Cardiovascular Innovation Center||Cleveland, Ohio, United States|
|Healthcare Venture Partners||Charleston, South Carolina, United States|
|Investment Management Corporation of Ontario||Canada, Ontario, Toronto|
|M&L Healthcare Investments||-|
|Mengyun Yiruan||China, Shanghai|
|Sasken Communication Technologies||Bengaluru, India, Karnataka|
|StartupXseed Ventures||Bangalore, India, Karnataka|
|Tandem Expansion||Canada, Montréal, Quebec|
|Tokio Marine Investment Services||Japan, Tokyo|
|Yitu Technology||China, Shanghai|
Chuangxin Huilian Technology
|08 Dec 2021||Nanjing, Jiangsu, China|
|29 Nov 2021||Palo Alto, California, United States|
|$15M||22 Nov 2021||Minhang, Shanghai, China|
|$300M||08 Oct 2021||Jiangyin City, Jiangsu, China|
|$100M||23 Sep 2021||Dongcheng District, Beijing, China|
|$15M||07 Jun 2021||Shanghai, China|
|$92M||04 Jun 2021||Xuanwu District, Jiangsu, China|
|$15M||19 Feb 2021||Shangcheng District, Zhejiang, China|
|$40M||04 Sep 2020||China, Beijing|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.